Specac, Ltd has acquired Amax Precision Ltd to enhance its technological capabilities and strengthen its position as a leading global partner in analytical instrumentation.

Information on the Target

Specac, Ltd ("Specac" or the "Group"), a portfolio company of Ampersand Capital Partners, is a prominent leader in the design and manufacture of spectroscopy accessories and sample preparation solutions. The Group recently announced its acquisition of Amax Precision Ltd ("Amax"), a global authority in precision contract manufacturing for analytical instruments. This strategic acquisition aims to enhance Specac's technological and manufacturing capabilities.

Amax specializes in high-precision engineering and manufacturing, including advanced assembly and testing services. The synergy between Amax's capabilities and Specac's module-based assembly approach fosters greater vertical integration, thereby enhancing the service suite offered to original equipment manufacturer (OEM) partners worldwide. Together, the newly formed entity operates with over 400 employees across three continents, establishing a significant presence near client production and engineering facilities.

Industry Overview in the Target’s Specific Country

The analytical instrumentation industry in the UK has been experiencing robust growth, driven by advancements in technology and increasing demand for precise measurements across various sectors including life scie

View Source

Similar Deals

Sheares Healthcare Group Homage

2021

Other Home Healthcare Services Singapore
DeepHealth See-Mode Technologies

Other Medical & Diagnostic Laboratories Singapore
Efor Process Engineering Specialists (PES)

Other Biotechnology & Medical Research (NEC) Singapore
Gannet BioChem Laysan Bio

2026

Other Proprietary & Advanced Pharmaceuticals United States of America

Specac, Ltd

invested in

Amax Precision Ltd

in 2026

in a Other deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert